The association between celiac disease and primary biliary cirrhosis ... of intestinal microbiome-associated and immunologically active molecules reaching the liver through the portal circulation ...

The breakdown of the gut–liver ... homing to the liver and an overload of intestinal microbiome-associated and immunologically active molecules reaching the liver through the portal circulation ...

Causes of portal hypertension can be prehepatic (such as portal vein thrombosis), hepatic (commonly liver cirrhosis and hepatic fibrosis) or posthepatic (such as hepatic vein obstruction).

Simvastatin could be an effective therapy for portal hypertension, according to a study by Abraldes and colleagues, which shows that the drug decreases portal hypertension and improves liver ...

Xiaolong Qi (Center of Portal Hypertension ... on the gut microbiome and metabolome of patients at risk for Alzheimer's disease (AD). In Germany, liver cirrhosis has the highest mortality rate ...

EnteroBiotix Limited (‘EnteroBiotix’ or the ‘Company’), a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced positive ...

EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, announced positive results from its phase 1b IMPuLCE study ...

Researchers are exploring a study on carbon beads, designed to tackle harmful bacteria and inflammation linked to liver ...

EnteroBiotix Limited ('EnteroBiotix' or the 'Company'), a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced positive ...